US2013323262A1PendingUtilityA1
Methods and materials for treating inflammatory conditions
Assignee: RES MAYO FOUNDATION FOR MEDICAL EDUCATION ANDPriority: May 21, 2002Filed: May 23, 2013Published: Dec 5, 2013
Est. expiryMay 21, 2022(expired)· nominal 20-yr term from priority
A61P 37/00G01N 2800/24C12Q 1/37G01N 2800/104A61K 2039/57C12Q 2600/158G01N 2800/102G01N 2800/285C07K 2317/76G01N 2333/96455G01N 33/564A61K 39/3955A61P 11/06C12Q 1/6883C07K 16/40
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and kits for treating inflammatory conditions are described that include modulating kallikrein 6 protease activity.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method for treating arthritis, lupus, or asthma, wherein said method comprises administering, to a mammal having arthritis, lupus, or asthma, an amount of a serine protease inhibitor effective to inhibit kallikrein 6 (K6) activity and treat said arthritis, lupus, or asthma.
18 . The method of claim 17 , wherein said method further comprises monitoring said arthritis, lupus, or asthma in said mammal.
19 . The method of claim 17 , wherein said method comprises treating arthritis.
20 . The method of claim 17 , wherein said method comprises treating lupus.
21 . The method of claim 17 , wherein said method comprises treating asthma.Join the waitlist — get patent alerts
Track US2013323262A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.